"Hospital in the South Central Kansas Health system."

During the past decade, Memorial Hospital of Arkansas City conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 4 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Memorial Hospital of Arkansas City" #1 collaborator was "National Cancer Institute (NCI)" with 2 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Cancer and Leukemia Group B" with 1 trials as a collaborator, "Eastern Cooperative Oncology Group" with 1 trials as a collaborator and "NCIC Clinical Trials Group" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Memorial Hospital of Arkansas City" are "Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome" (1 trials), "Adenocarcinoma of the Colon" (1 trials), "Adult Acute Megakaryoblastic Leukemia" (1 trials), "Adult Acute Monocytic Leukemia" (1 trials) and "Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11" (1 trials). Many other conditions were trialed in "Memorial Hospital of Arkansas City" in a lesser frequency.

Most popular intervention types in "Memorial Hospital of Arkansas City" are "Drug" (5 trials), "Other" (3 trials), "Procedure" (2 trials), "Biological" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (3 trials), "Imatinib Mesylate" (2 trials), "Clinical Observation" (1 trials), "Dasatinib" (1 trials) and "Exemestane" (1 trials). Other intervention names were less common.

The vast majority of trials in "Memorial Hospital of Arkansas City" are 4 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Memorial Hospital of Arkansas City". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Memorial Hospital of Arkansas City, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Memorial Hospital of Arkansas City, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".